Article
Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.
Human molecular genetics - 15 Oct 2009
Thein Swee Lay, Menzel Stephan, Lathrop Mark, Garner Chad
Abstract excerpt
Increased levels of fetal hemoglobin (HbF, alpha(2)gamma(2)) are of no consequence in healthy adults, but confer major clinical benefits in patients with sickle cell anemia (SCA) and beta thalassemia, diseases that represent major public health problems. Inter-individual HbF variation is largely genetically controlled, with one extreme caused by mutations involving the beta globin gene (HBB) complex, historically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
